HYB-2055
immunomodulatory oligonucleotide, an agonist of toll-like receptor 9, for the potential treatment of cancer; in phase II clinical trials (8/2005)
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures